LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

Начало・Списък с акции・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Затворен

1.5 -5.06

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.48

Максимум

1.5899999999999999

Ключови измерители
By Trading Economics
Приходи	17M -26M
EPS	-0.43
Марж на печалбата	-2,190.837
Служители	171
EBITDA	19M -23M

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	+81.82% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-1.1M 101M
Предишно отваряне	6.56
Предишно затваряне	1.5

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

1.43 / 1.6 Подкрепа & съпротива

Pliant Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

18.11.2025 г., 19:25 ч. UTC

Придобивния, сливания и поглъщания

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- 2nd Update

18.11.2025 г., 18:09 ч. UTC

Придобивния, сливания и поглъщания

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- Update

18.11.2025 г., 17:39 ч. UTC

Придобивния, сливания и поглъщания

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough

18.11.2025 г., 16:25 ч. UTC

Значими двигатели на пазара

Diginex Rises on Deal With Digital Asset Platform Evident

18.11.2025 г., 23:56 ч. UTC

Пазарно говорене

Gold Edges Higher on Likely Technical Recovery -- Market Talk

18.11.2025 г., 23:39 ч. UTC

Пазарно говорене

Nikkei May Rise on Bargain-Hunting Interest -- Market Talk

18.11.2025 г., 22:59 ч. UTC

Пазарно говорене

FireFly Metals Can Build Bigger Operation at Green Bay -- Market Talk

18.11.2025 г., 22:08 ч. UTC

Пазарно говорене

Sandfire's Kalkaroo Project Push Adds to Copper M&A Surge -- Market Talk

18.11.2025 г., 22:03 ч. UTC

Придобивния, сливания и поглъщания

Meta Defeats FTC's Antitrust Case Alleging Social-Media Monopoly -- 3rd Update

18.11.2025 г., 22:03 ч. UTC

Печалби

These Stocks Moved the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

18.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

18.11.2025 г., 21:15 ч. UTC

Пазарно говорене

Private High-Grade Credit Market Is Changing, BlackRock Says -- Market Talk

18.11.2025 г., 20:46 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Edge Up on Weather Outlook -- Market Talk

18.11.2025 г., 20:13 ч. UTC

Пазарно говорене

Distillate Supply Concerns Pull Crude Futures Higher -- Market Talk

18.11.2025 г., 19:48 ч. UTC

Пазарно говорене

Gold and Silver Turn Lower on Fed Outlook -- Market Talk

18.11.2025 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

Anheuser-Busch InBev Nears $700 Million Deal for Party Punch Maker BeatBox -- WSJ

18.11.2025 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

Anheuser-Busch InBev in Talks to Buy Party Punch Maker BeatBox, Sources Say -- WSJ

18.11.2025 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

AB InBev-BeatBox Deal Could Come Together Soon, Sources Say -- WSJ

18.11.2025 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

AB InBev Deal Would Value BeatBox At Around $700M, Sources Say -- WSJ

18.11.2025 г., 18:29 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18.11.2025 г., 18:18 ч. UTC

Пазарно говорене

Ethanol Demand Expected to Boost Corn Futures -- Market Talk

18.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

18.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

18.11.2025 г., 17:19 ч. UTC

Пазарно говорене

Печалби

Good Weather Was Bad News for Home Depot's 3Q -- Market Talk

18.11.2025 г., 17:06 ч. UTC

Печалби

Medtronic Stock Rises After Earnings. What Caught Investors' Attention. -- Barrons.com

18.11.2025 г., 16:06 ч. UTC

Придобивния, сливания и поглъщания

Intuit Stock Gains on OpenAI Deal. ChatGPT Is Coming to TurboTax. -- Barrons.com

18.11.2025 г., 15:59 ч. UTC

Печалби

Home Depot Cuts Outlook as Home Improvement Slowdown Continues -- Update

18.11.2025 г., 15:35 ч. UTC

Придобивния, сливания и поглъщания

Eni: Acquisition Adds to Plenitude's Installed-Capacity Targets, Bolsters France Presence

18.11.2025 г., 15:35 ч. UTC

Придобивния, сливания и поглъщания

Eni: Portfolio Comprises Capacity of Around 760MW in Operation

Сравнение с други в отрасъла

Ценова промяна

Pliant Therapeutics Inc Прогноза

Ценова цел

By TipRanks

81.82% нагоре

12-месечна прогноза

Среден 3 USD 81.82%

Висок 4 USD

Нисък 2 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Pliant Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

4 ratings

Купи

Задържане

Продай

Според 4 анализатори, дали борсови рейтинги на Pliant Therapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

1.43 / 1.6Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.